These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2931853)

  • 1. Reply to comments on two articles dealing with the teratogenicity of cyproterone acetate (CA) and medroxyprogesterone acetate (MPA).
    Spielmann H
    Teratology; 1985 Oct; 32(2):319-20. PubMed ID: 2931853
    [No Abstract]   [Full Text] [Related]  

  • 2. Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I.
    Eibs HG; Spielmann H; Hägele M
    Teratology; 1982 Feb; 25(1):27-36. PubMed ID: 6461082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. II. Cyproterone acetate and medroxyprogesterone acetate treatment before implantation in vivo and in vitro.
    Eibs HG; Spielmann H; Jacob-Müller U; Klose J
    Teratology; 1982 Jun; 25(3):291-9. PubMed ID: 6214037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiandrogens and medroxyprogesterone acetate on testicular morphometry in mice.
    Umapathy E; Rai UC
    Acta Morphol Acad Sci Hung; 1982; 30(2):99-108. PubMed ID: 6219551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 6. The hormonal treatment of sexual offenders.
    Bradford JM
    Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of antiandrogen cyproterone acetate on pregnant white laboratory mice].
    Heisler C
    Zentralbl Veterinarmed A; 1983 Nov; 30(9):694-7. PubMed ID: 6229112
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of antiandrogens on the accessory sex glands of castrated rats.
    Umapathy E; Rai UC
    Indian J Exp Biol; 1980 Oct; 18(10):1090-3. PubMed ID: 6452405
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychopharmacological therapy of deviant sexual behavior.
    Murray JB
    J Gen Psychol; 1988 Jan; 115(1):101-10. PubMed ID: 2965214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
    Pavone-Macaluso M; Ingargiola GB; de Voogt H; Viggiano G; Barasolo E; Lardennois B; De Pauw M; Sylvester R
    Prog Clin Biol Res; 1987; 243A():379-82. PubMed ID: 2958862
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on two recent papers dealing with the teratogenicity of medroxyprogesterone acetate.
    Marks TA
    Teratology; 1985 Apr; 31(2):313-5. PubMed ID: 3158091
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of gestational sex steroid exposure on limb development and endochondral ossification in the pregnant C57Bl/6J mouse: I. Medroxyprogesterone acetate.
    Carbone JP; Figurska K; Buck S; Brent RL
    Teratology; 1990 Aug; 42(2):121-30. PubMed ID: 2145652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of antiandrogens in psychiatry].
    Hoffet H
    Gynakologe; 1980 Mar; 13(1):33-43. PubMed ID: 6219928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M; Martínez-Piñeiro JA; de Voogt H; Lardennois B; Nasta A; Zolfanelli R; Barasolo E; De Pauw M; Suciu S; Sulvester R
    Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of precocious puberty].
    Fargasová I
    Cesk Pediatr; 1982 Oct; 37(10):590-3. PubMed ID: 6216969
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of sex offenses with antiandrogens].
    Kockott G
    Psychiatr Prax; 1983 Sep; 10(5):158-64. PubMed ID: 6227026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome.
    Hauffa BP; Havers W; Stolecke H
    Helv Paediatr Acta; 1987 Jun; 42(5-6):471-80. PubMed ID: 2969881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo-Provera: the jury still out.
    Gold RB
    Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of cyproterone acetate on aromatase activity in cultured human genital skin fibroblasts: intracellular control of aromatase activity].
    Fujimoto M
    Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):585-602. PubMed ID: 2551746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryotoxicity and maternal serum concentrations of medroxyprogesterone acetate (MPA) in baboons (Papio cynocephalus).
    Prahalada S; Carroad E; Hendrickx AG
    Contraception; 1985 Nov; 32(5):497-515. PubMed ID: 2935368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.